N-Heterocyclic carbene (NHC)-catalyzed oxidation of unactivated aldimines to amides via imine umpolung under aerobic conditions
Herein, we disclose an NHC-catalyzed aerobic oxidation of unactivated aldimines for the
synthesis of amides via umpolung of imines proceeding through an aza-Breslow …
synthesis of amides via umpolung of imines proceeding through an aza-Breslow …
An update on betrixaban, the challenging anticoagulant agent for extended venous thromboembolism prophylaxis
Y Daryabari, F Amreek… - Journal of …, 2022 - journals.lww.com
Venous thromboembolism (VTE) is a prevalent yet preventable cause of death, particularly
among hospitalized patients. Studies have shown that the risk of VTE remains high for up to …
among hospitalized patients. Studies have shown that the risk of VTE remains high for up to …
Preoperative management of anticoagulation in the surgical patient: Highlights of the latest guidelines
Oral anticoagulants (OACs) are a class of medications commonly used in the long-term
management of patients at risk of thrombosis. They include warfarin and direct oral …
management of patients at risk of thrombosis. They include warfarin and direct oral …
Use of direct oral anticoagulants in ICU patients. Part I–Applied pharmacology
Direct oral anticoagulants (DOACs) have revolutionized the field of anticoagulation in the
last decade, mainly due to their fixed dosing, rapid onset of anticoagulant effect, and non …
last decade, mainly due to their fixed dosing, rapid onset of anticoagulant effect, and non …
Antifosfolipidový syndrom a vliv přímých inhibitorů na stanovení lupus antikoagulans a možnosti jejich neutralizace
N Hemplová - 2024 - dk.upce.cz
Tato diplomová práce shrnuje v teoretické části informace o antifosfolipidovém sydnromu,
včetně antifosfolipidových protilátek a jejich možnému patologickému účinku v organismu …
včetně antifosfolipidových protilátek a jejich možnému patologickému účinku v organismu …
Nuevos anticoagulantes orales: comparación entre el edoxaban y el rivaroxaban en el manejo de la extracción dental. Una revisión sistemática
FV Villanueva - 2023 - titula.universidadeuropea.com
Rivaroxaban y edoxaban son nuevos anticoagulantes orales (NOACs) inhibidores del factor
Xa. En pacientes tratados con estos fármacos, el riesgo de hemorragia es aumentado …
Xa. En pacientes tratados con estos fármacos, el riesgo de hemorragia es aumentado …
[PDF][PDF] TÜM YÖNLERİ İLE AF VE TEDAVİ YAKLAŞIMLARI
V OKTAY - 2022 - scholar.archive.org
Bu üründe yer alan bilgiler sadece lisanslı tıbbi çalışanlar için kaynak olarak sunulmuştur.
Herhangi bir konuda profesyonel tıbbi danışmanlık veya tıbbi tanı amacıyla …
Herhangi bir konuda profesyonel tıbbi danışmanlık veya tıbbi tanı amacıyla …